These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 8836637
1. [3H]adenosine transport in DDT1 MF-2 smooth muscle cells: inhibition by metabolites of propentofylline. Parkinson FE, Mukherjee K, Geiger JD. Eur J Pharmacol; 1996 Jul 11; 308(1):97-102. PubMed ID: 8836637 [Abstract] [Full Text] [Related]
2. Nucleoside transporter-mediated uptake and release of [3H]L-adenosine in DDT1 MF-2 smooth muscle cells. Foga IO, Geiger JD, Parkinson FE. Eur J Pharmacol; 1996 Dec 30; 318(2-3):455-60. PubMed ID: 9016938 [Abstract] [Full Text] [Related]
3. Effect of adenosine receptor agonists on release of the nucleoside analogue [3H]formycin B from cultured smooth muscle DDT1 MF-2 cells. Borgland SL, Parkinson FE. Eur J Pharmacol; 1998 Apr 10; 346(2-3):339-44. PubMed ID: 9652378 [Abstract] [Full Text] [Related]
4. Inhibitory effects of propentofylline on [3H]adenosine influx. A study of three nucleoside transport systems. Parkinson FE, Paterson AR, Young JD, Cass CE. Biochem Pharmacol; 1993 Sep 01; 46(5):891-6. PubMed ID: 8373440 [Abstract] [Full Text] [Related]
5. Effects of propentofylline on adenosine A1 and A2 receptors and nitrobenzylthioinosine-sensitive nucleoside transporters: quantitative autoradiographic analysis. Parkinson FE, Fredholm BB. Eur J Pharmacol; 1991 Sep 24; 202(3):361-6. PubMed ID: 1748157 [Abstract] [Full Text] [Related]
6. A comparison of the abilities of nitrobenzylthioinosine, dilazep, and dipyridamole to protect human hematopoietic cells from 7-deazaadenosine (tubercidin). Cass CE, King KM, Montaño JT, Janowska-Wieczorek A. Cancer Res; 1992 Nov 01; 52(21):5879-86. PubMed ID: 1394215 [Abstract] [Full Text] [Related]
7. Further evidence that propentofylline (HWA 285) influences both adenosine receptors and adenosine transport. Fredholm BB, Fastbom J, Kvanta A, Gerwins P, Parkinson F. Fundam Clin Pharmacol; 1992 Nov 01; 6(3):99-111. PubMed ID: 1628877 [Abstract] [Full Text] [Related]
8. Characterization of inhibitor-sensitive and -resistant adenosine transporters in cultured human fetal astrocytes. Gu JG, Nath A, Geiger JD. J Neurochem; 1996 Sep 01; 67(3):972-7. PubMed ID: 8752102 [Abstract] [Full Text] [Related]
9. Inhibition of nucleoside and nucleobase transport and nitrobenzylthioinosine binding by dilazep and hexobendine. Plagemann PG, Kraupp M. Biochem Pharmacol; 1986 Aug 01; 35(15):2559-67. PubMed ID: 3741459 [Abstract] [Full Text] [Related]
10. Effects of iodotubercidin on adenosine kinase activity and nucleoside transport in DDT1 MF-2 smooth muscle cells. Parkinson FE, Geiger JD. J Pharmacol Exp Ther; 1996 Jun 01; 277(3):1397-401. PubMed ID: 8667202 [Abstract] [Full Text] [Related]
11. The kinetics of dissociation of the inhibitor of nucleoside transport, nitrobenzylthioinosine, from the high-affinity binding sites of cultured hamster cells. Koren R, Cass CE, Paterson AR. Biochem J; 1983 Nov 15; 216(2):299-308. PubMed ID: 6661198 [Abstract] [Full Text] [Related]
12. Species differences in sensitivity of nucleoside transport in erythrocytes and cultured cells to inhibition by nitrobenzylthioinosine, dipyridamole, dilazep and lidoflazine. Plagemann PG, Woffendin C. Biochim Biophys Acta; 1988 Apr 02; 969(1):1-8. PubMed ID: 3349106 [Abstract] [Full Text] [Related]
13. Involvement of bidirectional adenosine transporters in the release of L-[3H]adenosine from rat brain synaptosomal preparations. Gu JG, Foga IO, Parkinson FE, Geiger JD. J Neurochem; 1995 May 02; 64(5):2105-10. PubMed ID: 7722493 [Abstract] [Full Text] [Related]
14. Mutation of leucine-92 selectively reduces the apparent affinity of inosine, guanosine, NBMPR [S6-(4-nitrobenzyl)-mercaptopurine riboside] and dilazep for the human equilibrative nucleoside transporter, hENT1. Endres CJ, Sengupta DJ, Unadkat JD. Biochem J; 2004 May 15; 380(Pt 1):131-7. PubMed ID: 14759222 [Abstract] [Full Text] [Related]
16. Characterization of the uptake of adenosine by cultured rat hippocampal cells and inhibition of the uptake by xanthine derivatives. Ohkubo T, Mitsumoto Y, Mohri T. Neurosci Lett; 1991 Dec 09; 133(2):275-8. PubMed ID: 1816507 [Abstract] [Full Text] [Related]
17. Sodium-dependent and equilibrative nucleoside transport systems in L1210 mouse leukemia cells: effect of inhibitors of equilibrative systems on the content and retention of nucleosides. Dagnino L, Paterson AR. Cancer Res; 1990 Oct 15; 50(20):6549-53. PubMed ID: 1698538 [Abstract] [Full Text] [Related]
18. Effects of nucleoside transport inhibitors on the salvage and toxicity of adenosine and deoxyadenosine in L1210 and P388 mouse leukemia cells. Plagemann PG, Wohlhueter RM. Cancer Res; 1985 Dec 15; 45(12 Pt 1):6418-24. PubMed ID: 3877568 [Abstract] [Full Text] [Related]
19. Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep. SenGupta DJ, Unadkat JD. Biochem Pharmacol; 2004 Feb 01; 67(3):453-8. PubMed ID: 15037197 [Abstract] [Full Text] [Related]
20. Characteristics of an adenylate cyclase coupled beta 2-adrenergic receptor in a smooth muscle tumor cell line. Norris JS, Garmer DJ, Brown F, Popovich K, Cornett LE. J Recept Res; 1983 Feb 01; 3(5):623-45. PubMed ID: 6323709 [Abstract] [Full Text] [Related] Page: [Next] [New Search]